These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36306457)

  • 41. Three-dimensional imaging of the atrial septum and patent foramen ovale anatomy: defining the morphological phenotypes of patent foramen ovale.
    Rana BS; Shapiro LM; McCarthy KP; Ho SY
    Eur J Echocardiogr; 2010 Dec; 11(10):i19-25. PubMed ID: 21078835
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diagnosis of secondary source of right-to-left shunt with balloon occlusion of patent foramen ovale and power M-mode transcranial Doppler.
    Jesurum JT; Fuller CJ; Renz J; Krabill KA; Spencer MP; Reisman M
    JACC Cardiovasc Interv; 2009 Jun; 2(6):561-7. PubMed ID: 19539262
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Flatstent versus the conventional umbrella devices in the percutaneous closure of patent foramen ovale.
    Aral M; Mullen M
    Catheter Cardiovasc Interv; 2015 May; 85(6):1058-65. PubMed ID: 25413379
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sensitivity of transcranial Doppler versus intracardiac echocardiography in the detection of right-to-left shunt.
    Van H; Poommipanit P; Shalaby M; Gevorgyan R; Tseng CH; Tobis J
    JACC Cardiovasc Imaging; 2010 Apr; 3(4):343-8. PubMed ID: 20394894
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of patent foramen ovale closure in patients with platypnea-orthodeoxia syndrome.
    Mojadidi MK; Gevorgyan R; Noureddin N; Tobis JM
    Catheter Cardiovasc Interv; 2015 Oct; 86(4):701-7. PubMed ID: 26063336
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Medium-term results of transcatheter closure of patent foramen ovale (PFO) with Amplatzer PFO and Cribriform occluders.
    Białkowski J; Wawrzyńczyk M; Karwot B; Fiszer R; Knop M; Szkutnik M
    Kardiol Pol; 2012; 70(11):1142-6. PubMed ID: 23180522
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transcranial Doppler as a Screening Tool for High-Risk Patent Foramen Ovale in Cryptogenic Stroke.
    Park S; Oh JK; Song JK; Kwon B; Kim BJ; Kim JS; Kang DW; Chang JY; Lee JS; Kwon SU
    J Neuroimaging; 2021 Jan; 31(1):165-170. PubMed ID: 32896963
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reprint of : Transcatheter closure of patent foramen ovale to prevent stroke recurrence in patients with otherwise unexplained ischaemic stroke: Expert consensus of the French Neurovascular Society and the French Society of Cardiology.
    Mas JL; Derex L; Guérin P; Guillon B; Habib G; Juliard JM; Marijon E; Massardier E; Meneveau N; Vuillier F
    Rev Neurol (Paris); 2020; 176(1-2):53-61. PubMed ID: 31787326
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Percutaneous implantation of a second device in patients with residual right-to-left shunt after patent foramen ovale closure.
    Rovera C; Biasco L; Orzan F; Belli R; Omedè P; Gaita F
    J Interv Cardiol; 2014 Dec; 27(6):548-54. PubMed ID: 25421752
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Echocardiographic findings in simple and complex patent foramen ovale before and after transcatheter closure.
    Vitarelli A; Mangieri E; Capotosto L; Tanzilli G; D'Angeli I; Toni D; Azzano A; Ricci S; Placanica A; Rinaldi E; Mukred K; Placanica G; Ashurov R
    Eur Heart J Cardiovasc Imaging; 2014 Dec; 15(12):1377-85. PubMed ID: 25139906
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficiency of transcatheter patent foramen ovale closure in children after paradoxical embolism events.
    Wawrzyńczyk M; Gałeczka M; Karwot B; Knop M; Białkowski J
    Kardiol Pol; 2016; 74(4):385-9. PubMed ID: 26412471
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transcranial doppler quantification of residual shunt after percutaneous patent foramen ovale closure: efficacy of the GORE(®) HELEX septal occluder.
    Sorensen SG; Smout R; Spruance SL
    J Interv Cardiol; 2011 Aug; 24(4):366-72. PubMed ID: 21492220
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: the FORI (Foramen Ovale Registro Italiano) study.
    Paciaroni M; Agnelli G; Bertolini A; Pezzini A; Padovani A; Caso V; Venti M; Alberti A; Palmiero RA; Cerrato P; Silvestrelli G; Lanari A; Previdi P; Corea F; Balducci A; Ferri R; Falcinelli F; Filippucci E; Chiocchi P; Grandi FC; Ferigo L; Musolino R; Bersano A; Ghione I; Sacco S; Carolei A; Baldi A; Ageno W;
    Cerebrovasc Dis; 2011; 31(2):109-16. PubMed ID: 21088390
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Does transcatheter closure of patent foramen ovale really "shut the door?" A prospective study with transcranial Doppler.
    Anzola GP; Morandi E; Casilli F; Onorato E
    Stroke; 2004 Sep; 35(9):2140-4. PubMed ID: 15284445
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Percutaneous Closure of Patent Foramen Ovale in Patients With Migraine: The PREMIUM Trial.
    Tobis JM; Charles A; Silberstein SD; Sorensen S; Maini B; Horwitz PA; Gurley JC
    J Am Coll Cardiol; 2017 Dec; 70(22):2766-2774. PubMed ID: 29191325
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Patent foramen ovale with complex anatomy: Comparison of two different devices (Amplatzer Septal Occluder device and Amplatzer PFO Occluder device 30/35).
    Giordano M; Gaio G; Santoro G; Palladino MT; Sarubbi B; Golino P; Russo MG
    Int J Cardiol; 2019 Mar; 279():47-50. PubMed ID: 30344060
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anatomical patterns of patent foramen ovale (PFO): do they matter for percutaneous closure?
    Presbitero P; Lanzone AM; Albiero R; Lisignoli V; Zavalloni Parenti D; Gasparini GL; Lodigiani C; Barbaro C; Fappani A; Barberis G; Rossi ML; Pagnotta P
    Minerva Cardioangiol; 2009 Jun; 57(3):275-84. PubMed ID: 19513008
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of Outcomes after Device Closure and Medication Alone in Patients with Patent Foramen Ovale and Cryptogenic Stroke in Korean Population.
    Moon J; Kang WC; Kim S; Oh PC; Park YM; Chung WJ; Choi DY; Lee JY; Lee YB; Hwang HY; Ahn T
    Yonsei Med J; 2016 May; 57(3):621-5. PubMed ID: 26996560
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Device-less patent foramen ovale closure by radiofrequency thermal energy.
    Walpoth NB; Habermacher K; Moarof I; Watson S; Wahl A; Windecker S; Schönenberger C; Meier B
    Swiss Med Wkly; 2008 Feb; 138(7-8):108-13. PubMed ID: 18293120
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Embolic implications of combined risk factors in patients with patent foramen ovale (the CARPE criteria): consideration for primary prevention closure?
    Rigatelli G; Dell'Avvocata F; Giordan M; Braggion G; Aggio S; Chinaglia M; Roncon L; Cardaioli P; Chen JP
    J Interv Cardiol; 2009 Aug; 22(4):398-403. PubMed ID: 19515082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.